Sebaceoushyperplasia.com

Sebaceoushyperplasia.com is hosted in United States / Kirkland . Sebaceoushyperplasia.com uses HTTPS protocol. Number of used technologies: 4. First technologies: CSS, Html, Javascript, Number of used javascripts: 2. First javascripts: Results.js, Caf.js, Number of used analytics tools: 0. Its server type is: Apache/2.2.15 (CentOS).

Technologies in use by Sebaceoushyperplasia.com

Technology

Number of occurences: 4

CSS
Html
Javascript
Php

Javascripts

Number of occurences: 2

results.js
caf.js

Advertise

Number of occurences: 1

Google Adsense

Server Type

Apache/2.2.15 (CentOS)

Powered by

PHP/5.4.45

Conversion rate optimization
Clickable call number	Not founded!
Conversion form (contact form, subcriber)	Not founded!
Clickable email	Not founded!
CTA (call to action) button	Not founded!
List	Not founded!
Image	Not founded!
Enhancement	Not founded!
Responsive website	Not founded!
Facebook sharing	Not founded!
Google+ sharing	Not founded!
Twitter sharing	Not founded!
Linkedin sharing	Not founded!
Blog on the webiste	Not founded!

HTTPS (SSL) - Sebaceoushyperplasia.com

SSL certificate

name: /OU=Domain Control Validated/OU=EssentialSSL/CN=fb.dbbsrv.com
subject:
- OU:
  - 0: Domain Control Validated
  - 1: EssentialSSL
- CN: fb.dbbsrv.com
hash: 9d4f29cf
issuer:
- C: GB
- ST: Greater Manchester
- L: Salford
- O: COMODO CA Limited
- CN: COMODO RSA Domain Validation Secure Server CA
version: 2
serialNumber: 22090379677038369328936038634713640837
validFrom: 151112000000Z
validTo: 181111235959Z
validFrom_time_t: 1447286400
validTo_time_t: 1541980799
extensions:
- authorityKeyIdentifier: keyid:90:AF:6A:3A:94:5A:0B:D8:90:EA:12:56:73:DF:43:B4:3A:28:DA:E7
- subjectKeyIdentifier: 7D:36:59:1A:99:D2:FA:F2:BA:9D:BD:94:59:D4:80:50:99:7B:24:52
- keyUsage: Digital Signature, Key Encipherment
- basicConstraints: CA:FALSE
- extendedKeyUsage: TLS Web Server Authentication, TLS Web Client Authentication
- certificatePolicies: Policy: 1.3.6.1.4.1.6449.1.2.2.7 CPS: https://secure.comodo.com/CPS Policy: 2.23.140.1.2.1
- crlDistributionPoints: Full Name: URI:http://crl.comodoca.com/COMODORSADomainValidationSecureServerCA.crl
- authorityInfoAccess: CA Issuers - URI:http://crt.comodoca.com/COMODORSADomainValidationSecureServerCA.crt OCSP - URI:http://ocsp.comodoca.com
- subjectAltName: DNS:fb.dbbsrv.com, DNS:www.fb.dbbsrv.com

Meta - Sebaceoushyperplasia.com

Number of occurences: 3

Name:
Content: text/html; charset=UTF-8
Name: keywords
Content: sebaceous hyperplasia,health,health fitness
Name: robots
Content: index, follow

Server / Hosting

IP: 98.124.245.24
Latitude: 47.67
Longitude: -122.19
Country: United States
City: Kirkland

Rname

ns2.fabulous.com
ns1.fabulous.com
mail.b-io.co

Target

hostmaster.fabulous.com

HTTP Header Response

HTTP/1.1 200 OK Date: Fri, 05 Aug 2016 06:45:43 GMT Server: Apache/2.2.15 (CentOS) X-Powered-By: PHP/5.4.45 Set-Cookie: cfgrend=27; expires=Fri, 05-Aug-2016 06:55:43 GMT; path=/; domain=www.sebaceoushyperplasia.com Set-Cookie: pID=obfc4711n59g0738ijzoggko; expires=Thu, 30-Nov-2017 08:00:00 GMT; path=/ Set-Cookie: sID=obfc4711n59g0738ijzoggko; path=/ Set-Cookie: litelayout=18; expires=Fri, 05-Aug-2016 07:45:43 GMT; path=/; domain=www.sebaceoushyperplasia.com Set-Cookie: litecolor=21; expires=Fri, 05-Aug-2016 07:45:43 GMT; path=/; domain=www.sebaceoushyperplasia.com Set-Cookie: litelayout=18; expires=Fri, 05-Aug-2016 07:45:43 GMT; path=/; domain=www.sebaceoushyperplasia.com Set-Cookie: litecolor=21; expires=Fri, 05-Aug-2016 07:45:43 GMT; path=/; domain=www.sebaceoushyperplasia.com Set-Cookie: litelayout=18; expires=Fri, 05-Aug-2016 07:45:43 GMT; path=/; domain=www.sebaceoushyperplasia.com Set-Cookie: litecolor=21; expires=Fri, 05-Aug-2016 07:45:43 GMT; path=/; domain=www.sebaceoushyperplasia.com Set-Cookie: ddndestcycle=fd; expires=Fri, 02-Sep-2016 06:45:43 GMT; path=/; domain=www.sebaceoushyperplasia.com Content-Type: text/html; charset=UTF-8 X-Cache: MISS from s_hh40 X-Cache-Lookup: MISS from s_hh40:80 Transfer-Encoding: chunked Via: 1.1 s_hh40 (squid/3.5.11) Connection: keep-alive